Neurocrine Biosciences (NBIX) Inventory Average: 2017-2021
Historic Inventory Average for Neurocrine Biosciences (NBIX) over the last 3 years, with Sep 2021 value amounting to $26.9 million.
- Neurocrine Biosciences' Inventory Average rose 26.29% to $26.9 million in Q3 2021 from the same period last year, while for Sep 2021 it was $26.9 million, marking a year-over-year increase of 26.29%. This contributed to the annual value of $22.6 million for FY2020, which is 60.84% up from last year.
- As of Q3 2021, Neurocrine Biosciences' Inventory Average stood at $26.9 million, which was down 7.88% from $29.2 million recorded in Q2 2021.
- Neurocrine Biosciences' 5-year Inventory Average high stood at $29.2 million for Q2 2021, and its period low was $185,000 during Q3 2017.
- Moreover, its 3-year median value for Inventory Average was $21.3 million (2020), whereas its average is $20.1 million.
- Data for Neurocrine Biosciences' Inventory Average shows a peak YoY skyrocketed of 1,236.33% (in 2018) over the last 5 years.
- Quarterly analysis of 5 years shows Neurocrine Biosciences' Inventory Average stood at $633,000 in 2017, then surged by 1,236.33% to $8.5 million in 2018, then spiked by 66.08% to $14.0 million in 2019, then soared by 72.97% to $24.3 million in 2020, then climbed by 26.29% to $26.9 million in 2021.
- Its Inventory Average stands at $26.9 million for Q3 2021, versus $29.2 million for Q2 2021 and $29.1 million for Q1 2021.